Carmustine as a Supplementary Therapeutic Option for Glioblastoma: A Systematic Review and Meta-Analysis

Background: Glioblastoma (GBM) is the most aggressive type of primary malignant brain tumor. Carmustine is used by intravenous injection or local implantation in the resection cavity for gliomas, including GBMs. However, the therapeutic potential of carmustine is not well-recognized. This analysis a...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Zhi-Ze Xiao, Ze-Fen Wang, Tian Lan, Wen-Hong Huang, Yu-Hang Zhao, Chao Ma, Zhi-Qiang Li
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2020-09-01
Schriftenreihe:	Frontiers in Neurology
Schlagworte:	glioblastoma carmustine (BCNU) overall survival (OS) meta-analysis chemotherapy
Online-Zugang:	https://www.frontiersin.org/article/10.3389/fneur.2020.01036/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!